1. Process map proposal for the validation of genomic biomarkers
2. U.S. FDA. 2005a. Guidance for industry—Pharmacogenomic data submissions. Available at http://www.fda.gov/cder/guidance/6400fnl. pdf. Accessed on December 16, 2006.
3. U.S. FDA. 2005b. Guiding principles processing joint FDA EMEA voluntary genomic data submissions (VGDSs) within the framework of the confidentiality arrangement. Available at http://www. emea.europa.eu/pdfs/general/direct/pr/FDAEMEA.pdf. Accessed on December 16, 2006.
4. U.S. FDA. 2006a. Concept paper on recommendations for the generation and submission of genomic data. Available at http://www.fda.gov/cder/genomics/conceptpaper_20061107.pdf. Accessed on December 16, 2006.
5. U.S. FDA. 2006b. Predictive safety testing consortium. Available at http://www.fda.gov/oc/initiatives/criticalpath/projectsummary/consortium.html. Accessed on December 16, 2006.